Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Nov 7, 2016 · 10-Q · 38 days after period end · 0001564590-16-027821
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$56.74M | -$51.94M | -$29.23M | -$42.03M |
| EPS Diluted | -$1.18 | -$1.25 | -$0.71 | -$1.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 7, 2016 · 38 d after period end
